TSCAN THERAPEUTICS, INC. (TCRX) Total liabilities 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) total liabilities at each fiscal year-end, per SEC filings.
$105.7MFY2025 · since FY2020: $32.5M → $105.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $105.7M | -18.8% |
| FY2024 | $130.1M | +7.3% |
| FY2023 | $121.3M | +21.7% |
| FY2022 | $99.7M | +264.7% |
| FY2021 | $27.3M | -16.0% |
| FY2020 | $32.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice